**Core Concept**
Psoriasis is a chronic inflammatory skin disease characterized by hyperproliferation of keratinocytes and immune system dysregulation. Treatment options aim to reduce inflammation, slow down keratinocyte growth, and modulate the immune response. Various pharmacological agents are used to manage psoriasis, including biologics, systemic agents, and topical treatments.

**Why the Correct Answer is Right**
Biologics are a class of drugs that target specific molecules involved in the pathogenesis of psoriasis. They include tumor necrosis factor-alpha (TNF-alpha) inhibitors, interleukin-17 (IL-17) inhibitors, and interleukin-23 (IL-23) inhibitors. These agents have been shown to be effective in reducing psoriasis symptoms by modulating the immune response and preventing keratinocyte hyperproliferation. Examples of biologics used in psoriasis treatment include etanercept, adalimumab, ustekinumab, and secukinumab.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it is a biologic agent used to treat psoriasis, specifically targeting the IL-17 pathway.
**Option B:** This option is incorrect because it is a biologic agent used to treat psoriasis, specifically targeting the IL-23 pathway.
**Option C:** This option is incorrect because it is a biologic agent used to treat psoriasis, specifically targeting the TNF-alpha pathway.

**Clinical Pearl / High-Yield Fact**
When treating psoriasis, it is essential to consider the potential side effects and interactions of biologic agents, particularly with immunosuppressive drugs and live vaccines. Patients on biologics should also be screened for latent tuberculosis before starting treatment.

**Correct Answer: D.**